Drugs for Prostate Cancer

Table. Drugs Prescribed for Prostate Cancer

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Emcyt (estramustine phosphate sodium) Capsules
Drug company
• Pfizer
Indication
• Palliative treatment of metastatic and/or progressive prostate cancer
Patient support services
• Pfizer Patient Assistance Program
  866-706-2400
  
  Pfizer Savings Program
  855-239-9869

Drug name (generic name)
• Erleada (apalutamide) Tablets
Drug company
• Janssen Biotech
Indication
• Treatment of nonmetastatic castration-resistant prostate cancer
  
  Treatment of metastatic castration-sensitive prostate cancer
Patient support services
• Janssen CarePath Savings Program
  877-227-3728
  
  Johnson & Johnson Patient Assistance Foundation
  800-652-6227
  
  Janssen Compass
  844-NAV-1234

Drug name (generic name)
• Jevtana (cabazitaxel) Injection
Drug company
• Sanofi Genzyme
Indication
• Treatment of hormone-refractory metastatic prostate cancer, in combination with prednisone, after a docetaxel-based regimen
Patient support services
• CareASSIST Copay Program
  833-930-2273
  
  CareASSIST Patient Assistance Program
  833-930-2273

Drug name (generic name)
• Lynparza (olaparib) Capsules/Tablets
Drug company
• AstraZeneca
Indication
• Treatment of patients with metastatic castration-resistant prostate cancer and deleterious or suspected deleterious germline or somatic HRR gene mutation, as determined by an FDA-approved test, in men whose disease progressed after enzalutamide or abiraterone therapy
Patient support services
• Lynparza Co-pay Savings Program
  844-275-2360
  
  AZ&Me Prescription Savings Program
  800-292-6363

Drug name (generic name)
• Nubeqa (darolutamide) Tablets
Drug company
• Bayer
Indication
• Treatment of nonmetastatic castration-resistant prostate cancer
  
  Treatment, in combination with docetaxel, of adult patients with metastatic hormone-sensitive prostate cancer (mHSPC)
Patient support services
• Nubeqa Free Trial Program
  833-337-3833
  
  Nubeqa $0 Co-Pay Program
  647-245-5642
  
  Bayer US Patient Assistance Foundation
  866-228-7723

Drug name (generic name)
• Orgovyx (relugolix) Tablets
Drug company
• Myovant Sciences
Indication
• Treatment of patients with advanced prostate cancer
Patient support services
• Orgovyx Copay Assistance Program
  833-674-6899
  
  Myovant Patient Assistance Program
  833-674-6899

Drug name (generic name)
• Pluvicto (lutetium Lu 177 vipivotide tetraxetan) Injection
Drug company
• Advanced Accelerator Applications
Indication
• Treatment of adult patients with PSMA-positive mCRPC who have been treated with AR pathway inhibition and taxane-based chemotherapy
Patient support services
• AAA PatientCONNECT co-pay program
  844-638-7222

Drug name (generic name)
• Premarin (conjugated estrogens) Tablets
Drug company
• Pfizer
Indication
• Palliative treatment of advanced, androgen-dependent prostate cancer
Patient support services
• Premarin Savings Card
  866-410-3700
  
  Pfizer Patient Assistance Program
  877-744-5675

Drug name (generic name)
• Provenge (sipuleucel-T)
Drug company
• Dendreon
Indication
• Treatment of metastatic castration-resistant (hormone-refractory) prostate cancer
Patient support services
• PROvide Commercial Co-pay Program
  877-336-3736
  
  Co-pay Assistance for Patients with Medicare
  877-336-3736
  
  Provenge Uninsured Patient Program
  877-336-3736

Drug name (generic name)
• Pylarify (Piflufolastat F18) Injection
Drug company
• Progenics Pharmaceuticals
Indication
• For use with PET scan of men with PSMA-positive prostate cancer lesions and suspected metastasis who are candidates for initial definitive therapy or men with suspected recurrence based on elevated serum PSA level
Patient support services
• Pylarify Patient Support Program
  844-339-8514

Drug name (generic name)
• Rubraca (rucaparib) Tablets
Drug company
• Clovis Oncology
Indication
• Treatment of adults with metastatic castration-resistant prostate cancer and a deleterious (germline and/or somatic) BRCA mutation, as detected by an FDA-approved test, who have received androgen receptor therapy and a taxanebased chemotherapy
Patient support services
• Rubraca $0 Co-Pay Program
  844-779-7707
  
  Rubraca Connections Patient Assistance Program
  844-779-7707
  
  Rubraca Connections QuickStart Program
  844-779-7707
  
  Rubraca Coverage Link Program
  844-779-7707

Drug name (generic name)
• Xofigo (radium Ra 223 dichloride) Injection
Drug company
• Bayer
Indication
• Treatment of castration-resistant prostate cancer
Patient support services
• Xofigo Access Services $0 Copay
  855-696-3446
  
  Xofigo Access Services Financial Assistance Program
  855-696-3446

Drug name (generic name)
• Xtandi (enzalutamide) Tablets
Drug company
• Astellas Pharma
Indication
• Treatment of castration-resistant prostate cancer
  
  Treatment of patients with metastatic castration-sensitive prostate cancer
Patient support services
• XTANDI Patient Savings Program
  855-217-8311
  
  XTANDI Quick Start+ Program
  
  Astellas Patient Assistance Program
  855-898-2634

Drug name (generic name)
• Yonsa (abiraterone acetate) Tablets
Drug company
• Sun Pharma
Indication
• Treatment of metastatic castration-resistant prostate cancer, in combination with methylprednisolone
Patient support services
• Yonsa Copay Program
  855-984-6307
  
  Yonsa Early Access Program
  877-872-6575

Drug name (generic name)
• Zoladex (goserelin) Implant
Drug company
• TerSera Therapeutics
Indication
• Treatment of localized prostate cancer, in combination with flutamide
  
  Palliative treatment of advanced prostate cancer
Patient support services
• Zoladex Co-Pay Card
  844-864-3014
  
  Zoladex Patient Assistance Program
  855-686-8725

Drug name (generic name)
• Zytiga (abiraterone acetate) Tablets
Drug company
• Janssen Biotech
Indication
• Treatment of metastatic castration-resistant prostate cancer, in combination with prednisone
  
  Treatment of metastatic high-risk castration-sensitive prostate cancer, in combination with prednisone
Patient support services
• Janssen CarePath Savings Program
  855-998-4421
  
  Johnson & Johnson Patient Assistance Foundation
  800-652-6227